BioSpace News Archive

Cytokinetics, Incorporated announced that on January 29, 2021 it granted stock options to purchase an aggregate of 13,500 shares of common stock to Cinzia Ellero, a new employee whose employment commenced in January 2021 as a material inducement to her employment.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that the Compensation Committee of Karyopharm’s Board of Directors granted stock options to purchase an aggregate of 165,500 shares of Karyopharm’s common stock to 31 newly-hired employees, with a grant date of January 29, 2021.

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing of its previously announced underwritten public offering of its common stock.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Rob Schott, MD, MPH, FACC, as Senior Vice President and Head of Development.

Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced that financial results for the fourth quarter and fiscal year 2020 will be released before the market opens on Wednesday, March 31.

Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced the closing of its previously announced private placement of approximately $10.0 million through the issuance of an aggregate 2,758,624 shares of its common stock and warrants to purchase up to an aggregate 2,758,624 shares of common stock

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has added new surgeons to its platform in Arizona.

Amid recent reports that the U.S. ranks 43rd globally for sequencing to find new SARS-CoV-2 variants, AIDS Healthcare Foundation calls on the Biden administration to utilize the Defense Production Act to seek out new virus strains—a proactive move that would provide a sufficient number of requisitioned labs to ensure the United States is operating at maximum research capacity.

CF PharmTech, Inc. is a fully integrated pharmaceutical company in China specializing in the treatment of respiratory diseases.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced the pricing of an underwritten public offering of 9,100,000 shares of its common stock at a public offering price of $11.00 per share.